Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.4370
-0.0203-4.44%
Volume:284.61K
Turnover:128.71K
Market Cap:8.52M
PE:-0.41
High:0.4700
Open:0.4700
Low:0.4370
Close:0.4573
Loading ...
Mar 16, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 24, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 10, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 19, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 06, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 06, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 29, 2021

Major Issues Report

8-K - Current report
Jun 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 11, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 11, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 27, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 26, 2021

Correspondence

CORRESP [Cover] - Correspondence